The FDA approval of Thermo Fisher’s Oncomine Dx Express Test marks a key advancement in precision oncology, enabling fast, accurate detection of EGFR exon 20 insertion mutations and guiding NSCLC patients to targeted treatments like ZEGFROVY....
Pivotal U.S. Trial Evaluates Safety and Effectiveness of Onyx™ for Managing Bleeding in Peripheral Vasculature...
Next-Generation Platforms Deliver High Throughput, Precision, and Workflow Optimization in Coagulation Testing...
New Platform Offers Three Genomic Tests to Tailor Treatment Strategies for Glioblastoma Patients ...
Next-generation embolic technology enables rapid resorption and improved patient comfort in minimally invasive neurointervention...
Latest AI-driven upgrade empowers radiology teams with streamlined, high-quality image reconstruction and enhanced workflow efficiency across MRI systems globally....
New AI-Driven Platform Aims to Revolutionize Early Detection, Personalization, and Access in Global Mental Health Care...
Strategic Move Marks Safe Life’s Entry into the Asian Market, Strengthening Its Position in Health Technology Management Across the Region...
The regulatory milestone enables the use of Medtronic’s trusted vessel sealing technology on its Hugo™ robotic-assisted surgery platform, enhancing precision and expanding clinical versatility across Europe. ...
FDA-cleared Magnetic-Assisted Robotic Surgery (MARS™) platform achieves major clinical milestone, signaling growing adoption and impact in abdominal procedures across U.S. centers. ...
